GeneDx to Participate in Upcoming Investor Conferences

STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June:

• Jefferies Healthcare Conference - New York City, New York
  Fireside chat on Wednesday, June 5 at 9:00 a.m. ET
• 44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida
  Fireside chat on Monday, June 10 at 3:20 p.m. ET

Live and archived webcasts of the presentation will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

Investor Relations Contact:
[email protected]

Media Contact:
[email protected]

You May Also Be Interested In

• Zenbody RX Launches Telehealth Platform Built Around Personalized, Clinician-Guided GLP-1 Care
• Best Crypto Presale: Is DigiTap’s Product Ahead of Its Token Price? $0.0589 TAP Fuels a 100x Debate
• CLARITY Act Vote Lands September 15, 6 Best Crypto Presales Ahead of Crypto’s Big Washington Test